Coagulazione, infiammazione e CVD

Titolo	Data creazione	Visite
Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus	20 Giugno 2017	Visite: 38
Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction	23 Maggio 2017	Visite: 48
Association between adherence to dietary recommendations and highsensitivity C-reactive protein level in type 1 diabetes	24 Aprile 2017	Visite: 76
Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes	28 Marzo 2017	Visite: 70
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study	28 Febbraio 2017	Visite: 191
Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation	30 Gennaio 2017	Visite: 125
The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial	30 Dicembre 2016	Visite: 128
Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance	06 Dicembre 2016	Visite: 146
Effect of linagliptin on vascular function: a randomized, placebo-controlled study	08 Novembre 2016	Visite: 187
Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins	11 Ottobre 2016	Visite: 151

Pagina 1 di 4

Ricerca

Cookie